Tailor-Made Dual pH-Sensitive Polymer–Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery-Reference-Cited by-同舟云学术

Tailor-Made Dual pH-Sensitive Polymer–Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery

Published:2011-10-17 Issue:44 Volume:133 Page:17560-17563
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Du Jin-Zhi¹,Du Xiao-Jiao²,Mao Cheng-Qiong²,Wang Jun²

Affiliation:

1. CAS Key Laboratory of Soft Matter Chemistry, and Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei, Anhui 230026, P. R. China

2. CAS Key Laboratory of Brain Function and Disease, and School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, P. R. China

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja207150n

Reference39 articles.

1. Impact of Nanotechnology on Drug Delivery

2. Nanocarriers as an emerging platform for cancer therapy

3. Micellar Nanocarriers: Pharmaceutical Perspectives

4. Polymeric anticancer drugs with pH-controlled activation

5. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

Cited by 1090 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complexity made easy: Aggregation‐induced emission small molecules for cancer diagnosis and phototherapies;Aggregate;2024-09-02

2. Celastrol Derivative/DOX Co-Assembled Nanodrug for Enhanced Antitumor Therapy;Current Drug Delivery;2024-08-26

3. pH-Sensitive Polymer–Drug Conjugates;Chemistry of Materials;2024-08-17

4. Intertumoral and intratumoral barriers as approaches for drug delivery and theranostics to solid tumors using stimuli-responsive materials;Microchimica Acta;2024-08-16

5. Things to Know and Latest Trends in the Design and Application of Nanoplatforms in Cancer Treatment;BioNanoScience;2024-08-12